ARCHIVES

Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.”

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

ODAC Recommends FDA Approval For Grain Tumor Implant

June 21, 1996

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

December 7, 2012

Two “optimists” present different visions for rapid progress in cancer research at American Association for Cancer Research annual meeting. Leland Hartwell advocates genome-like project for molecular diagnostics. Andrew von Eschenbach describes “fantasies, dreams, visions” becoming reality.

April 9, 2004

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

Steckel Object To Remarks By Korn Comparing Southern California Centers Unfavorably To NCCP Consortium

November 2, 1984